Peter Hamblin

Sepsis and adrenal insufficiency: a potentially lethal combination

Peter S Hamblin, Bu B Yeap, David J Torpy

Journal article  |  2021  |  The Medical Journal of Australia

Diabetic ketoacidosis: a canary in the mine for mental health disorders?

Peter S Hamblin, Azni L Abdul-Wahab, Sylvia FB Xu, Cheryl E Steele, Sara Vogrin

Journal article  |  2021  |  Internal Medicine Journal

BACKGROUND: Recurrent diabetic ketoacidosis (DKA) has been linked to mental health disorders, but less is known about single DKA e..

Determinants of Cardiovascular Risk in 7000 Youth With Type 1 Diabetes in the Australasian Diabetes Data Network

Jenny J Couper, Timothy W Jones, Melissa Chee, Helen L Barrett, Philip Bergman, Fergus Cameron, Maria E Craig, Peter Colman, Elizabeth E Davis, Kim C Donaghue, P Gerry Fegan, P Shane Hamblin, D Jane Holmes-Walker, Craig Jefferies, Stephanie Johnson, Meng Tuck Mok, Bruce R King, Richard Sinnott, Glenn Ward, Benjamin J Wheeler, et al.

Journal article  |  2021  |  The Journal of Clinical Endocrinology & Metabolism

CONTEXT: Cardiovascular disease occurs prematurely in type 1 diabetes. The additional risk of overweight is not well characterized..

Sodium-glucose cotransporter type 2 inhibitors: managing the small but critical risk of diabetic ketoacidosis

Peter S Hamblin, Rosemary Wong, Leon A Bach

Journal article  |  2020  |  The Medical Journal of Australia

EatSmart, a Web-Based and Mobile Healthy Eating Intervention for Disadvantaged People With Type 2 Diabetes: Protocol for a Pilot Mixed Methods Intervention Study

Nazgol Karimi, David Crawford, Rachelle Opie, Ralph Maddison, Stella O'Connell, Peter Shane Hamblin, Ashley Huixian Ng, Cheryl Steele, Bodil Rasmussen, Kylie Ball

Journal article  |  2020  |  JMIR Research Protocols

BACKGROUND: People of low socioeconomic position (SEP) are disproportionately affected by type 2 diabetes (T2D), partly due to unh..

Successful medical management of insulinoma with diazoxide for 27 years

Annabelle M Warren, Duncan J Topliss, Peter Shane Hamblin

Journal article  |  2020  |  Endocrinology Diabetes and Metabolism Case Reports

Evolving Evidence of Diabetic Ketoacidosis in Patients Taking Sodium-Glucose Cotransporter 2 Inhibitors

Nicola Fleming, Peter Shane Hamblin, David Story, Elif Ekinci

Journal article  |  2020  |  The Journal of Clinical Endocrinology & Metabolism

INTRODUCTION: Sodium glucose cotransporter 2 inhibitors (SGLT2i) have emerged as an important class of blood glucose-lowering medi..

Prolactin ordering patterns in psychiatric inpatients and the impact this has on patient management

Annabel S Jones, Shoshana Sztal-Mazer, Ilan Rauchberger, Peter Shane Hamblin

Journal article  |  2020  |  Australasian Psychiatry

Significant Benefits of AIP Testing and Clinical Screening in Familial Isolated and Young-onset Pituitary Tumors

Pedro Marques, Francisca Caimari, Laura C Hernandez-Ramirez, David Collier, Donato Iacovazzo, Amy Ronaldson, Kesson Magid, Chung Thong Lim, Karen Stals, Sian Ellard, Ashley B Grossman, Marta Korbonits

Journal article  |  2020  |  Journal of Clinical Endocrinology and Metabolism

Sodium-glucose cotransporter type 2 inhibitors: managing the small but critical risk of diabetic ketoacidosis

Peter S Hamblin, Rosemary Wong, Leon A Bach

Journal article  |  2020  |  The Medical Journal of Australia